-
Allergan Continues Educational Strategy Amid FDA's Report Linking Breast Implants To Rare Cancer
Wednesday, March 22, 2017 - 10:19am | 421Read More...Following a Tuesday report by the Food and Drug Administration linking breast implants to anaplastic large cell lymphoma (ALCL), an Allergan plc Ordinary Shares (NYSE: AGN) spokesperson told Benzinga the company is responding to the report with patient and public education. “[We are] working...


